Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Jun 2024
Historique:
received: 17 04 2024
revised: 29 05 2024
accepted: 30 05 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: epublish

Résumé

For patients with hereditary breast and ovarian cancer, the probability of carrying two pathogenic variants (PVs) in dominant cancer-predisposing genes is rare. Using targeted next-generation sequencing (NGS), we investigated a 49-year-old Caucasian woman who developed a highly aggressive breast tumor. Our analyses identified an intragenic germline heterozygous duplication in

Identifiants

pubmed: 38892462
pii: ijms25116274
doi: 10.3390/ijms25116274
pii:
doi:

Substances chimiques

Tumor Suppressor Protein p53 0
BRCA1 Protein 0
TP53 protein, human 0
BRCA1 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Vuthy Ea (V)

UM Génétique Moléculaire: Maladies Héréditaires et Oncologie, University Hospital Grenoble Alpes, 38000 Grenoble, France.
INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble Alpes University, 38000 Grenoble, France.

Claudine Berthozat (C)

Department of Medical Oncology, Cancer and Blood Diseases, Grenoble Alpes University Hospital, 38000 Grenoble, France.

Hélène Dreyfus (H)

Genetic Service, Department of Genetics and Procreation, University Hospital Grenoble Alpes, 38000 Grenoble, France.

Clémentine Legrand (C)

Genetic Service, Department of Genetics and Procreation, University Hospital Grenoble Alpes, 38000 Grenoble, France.

Estelle Rousselet (E)

Genetic Service, Department of Genetics and Procreation, University Hospital Grenoble Alpes, 38000 Grenoble, France.

Magalie Peysselon (M)

Genetic Service, Department of Genetics and Procreation, University Hospital Grenoble Alpes, 38000 Grenoble, France.

Laura Baudet (L)

Genetic Service, Department of Genetics and Procreation, University Hospital Grenoble Alpes, 38000 Grenoble, France.

Guillaume Martinez (G)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble Alpes University, 38000 Grenoble, France.
UM de Génétique Chromosomique, University Hospital Grenoble Alpes, 38000 Grenoble, France.

Charles Coutton (C)

INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble Alpes University, 38000 Grenoble, France.
UM de Génétique Chromosomique, University Hospital Grenoble Alpes, 38000 Grenoble, France.

Marie Bidart (M)

UM Génétique Moléculaire: Maladies Héréditaires et Oncologie, University Hospital Grenoble Alpes, 38000 Grenoble, France.
INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble Alpes University, 38000 Grenoble, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH